2030 年微载体市场报告(按细分市场、地域、动态、最新发展和战略见解)

  • Report Code : TIPBT00002183
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 185
Buy Now

Microcarriers Market Size, Scope, Growth & Outlook 2030

Buy Now

 

微载体市场 规模预计将从 2022 年的 16.2584 亿美元增长到 2030 年的 41.7886 亿美元;预计 2022-2030 年期间市场复合年增长率为 12.5%。

 

市场洞察和分析师观点:

微载体有多种用途,从细胞培养到药物输送。它们通过提供更大的细胞附着表面积来刺激培养基中细胞的生长。它们可用于疫苗生产、生物制药和干细胞研究等应用。微载体市场的增长归因于对基于细胞的疫苗和疗法的需求不断增长、糖尿病、癌症、血友病、类风湿性关节炎等各种疾病和病症的发病率不断上升、对创新疗法开发的巨额投资以及细胞生物学研究的持续技术进步。

在微载体市场运营的公司正专注于战略发展,例如合作、扩张、协议、伙伴关系和新产品发布,这有助于他们提高销售额、扩大地理覆盖范围并增强满足现有客户群更大需求的能力。例如,2023 年 10 月,Kuraray Co., Ltd. 开发了用于再生医学细胞培养的PVA 水凝胶 微载体。该产品计划于 2024 年 1 月在日本和海外上市,首先在美国上市。

 

增长动力:

 

癌症和传染病发病率上升,对细胞疗法的需求增加

世界卫生组织 (WHO) 表示,到 2040 年,全球癌症负担预计将上升至 2750 万新病例和 1630 万死亡病例。美国癌症协会预测,2022 年美国将新增 1,918,030 例癌症病例和 609,360 例相关死亡病例,其中每天有近 350 人死于肺癌,肺癌是癌症死亡的主要原因。根据澳大利亚健康与福利研究所的数据,2020-2021 年,澳大利亚因传染病住院的人数超过 324,000 人,因 COVID-19 感染住院的人数超过 4,700 人。此外,2021 年共有 160 万人死于结核病 (TB)(包括 187,000 名艾滋病毒感染者)。结核病在全球死亡原因中排名第13位,在全球传染病死亡原因中排名第二,仅次于新冠肺炎(超过艾滋病毒和艾滋病)。

可以有效应用细胞疗法的疾病(如癌症、泌尿系统疾病、自身免疫性疾病和传染病)的发病率不断上升,这与微载体市场的增长有关。微载体是用于在搅拌槽式生物反应器中培养粘附细胞的小球体或颗粒(直径通常为 90-300 µm)。随着癌症和各种传染病发病率的不断上升,对适当药物和疫苗的需求也随之增加,这有利于微载体市场的增长。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

微载体市场:

Microcarriers Market: Strategic Insights

Microcarriers Market
  • CAGR
    CAGR (2022 - 2030)
    12.5%
  • Market Size 2022
    US$ 1.63 Billion
  • Market Size 2030
    US$ 4.18 Billion

Market Dynamics

GROWTH DRIVERS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Key Players

  • Teijin Ltd
  • Bio Rad Laboratories Inc
  • denovoMATRIX GmbH
  • Sartorius AG
  • Danaher Corp
  • Corning Inc
  • Eppendorf SE
  • Percell Biolytica AB
  • Asahi Kasei Corp

Regional Overview

Regional And Country Scope
  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

Segment 1产品(培养基、试剂、微载体珠)
    Segment2设备(生物反应器、培养容器等)
      Segment3应用(生物制药生产、细胞和基因治疗、组织工程和再生医学等)
        Segment4最终用户(制药和生物技术公司、合同研究组织和合同制造组织以及学术和研究机构)

          微载体市场
          • Microcarriers Market
            复合年增长率(2022 - 2030 年)
            12.5%
          • 2022 年市场规模
            16.3 亿美元
          • 2030 年市场规模
            41.8 亿美元

          市场动态

          增长动力
          • 財政部
          • 財政部
          • 財政部
          未来的趋势
          • 財政部
          • 財政部
          • 財政部
          机会
          • 財政部
          • 財政部
          • 財政部

          关键人物;主力;重要一员

          •  
          • 帝人株式会社
          • Bio-Rad 实验室公司
          • denovoMATRIX有限公司
          • 赛多利斯公司
          • 丹纳赫公司
          • 康宁公司
          • 艾本德
          • Percell Biolytica 公司
          • 旭化成公司

          区域概况

          Microcarriers Market
          • 北美
          • 欧洲
          • 亚太
          • 南美洲和中美洲
          • 中东和非洲

          市场细分

          Microcarriers Market产品
          • 培养基和试剂
          • 微载体珠
          Microcarriers Market设备
          • 生物反应器
          • 培养容器
          • 其他的
          Microcarriers Market应用
          • 生物制药生产
          • 细胞和基因治疗
          • 组织工程与再生医学
          • 其他的
          Microcarriers Market最终用户
          • 制药和生物技术公司
          • 合同研究组织和合同制造组织
          • 学术及研究机构
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

           

          报告细分和范围:

          “微载体市场”根据产品、设备、应用和最终用户进行细分。根据产品,市场分为微载体珠和培养基与试剂。根据设备,微载体市场分为生物反应器、培养容器和其他。根据应用,市场分为生物制药生产、细胞和基因治疗、组织工程和再生医学和其他。生物制药生产细分市场细分为治疗性蛋白质和疫苗生产。根据最终用户,市场细分为制药和生物技术公司、合同研究组织和合同制造组织以及学术和研究机构。

           

          节段分析:

          根据产品,微载体市场分为微载体珠、培养基和试剂。2022 年,微载体珠细分市场占据最大市场份额,预计在 2022-2030 年期间,微载体珠的复合年增长率将达到 12.8%。细胞生物学研究的不断增长、对再生医学和生物制药的需求以及多家制造商和供应商的存在,促进了微载体珠市场的大幅增长。广泛的产品供应和微载体技术的不断发展为主要市场参与者的增长提供了丰厚的机会。Sartorius AG 等主要公司提供不含动物成分和蛋白质涂层的微载体珠。

          根据设备,微载体市场细分为生物反应器、培养容器和其他。2022 年,生物反应器占据了最大的市场份额,预计在 2022-2030 年期间,生物反应器的复合年增长率将达到 12.8%。生物反应器是进行生物反应的制造设备或容器;它们用于在受控条件下在适当的环境中培养微生物,例如酵母、细菌或动物细胞。基于微载体的生物反应器可以实时离线监测细胞生长以及质量和代谢物分析,可用于检测错误并立即纠正。

          根据应用,微载体市场细分为生物制药生产、细胞和基因治疗、组织工程和再生医学等。2022 年,生物制药生产领域占据最大市场份额,预计在 2022-2030 年期间,生物制药生产领域将实现最快的复合年增长率,为 13.1%。生物制药生产领域进一步细分为治疗生产和疫苗生产。微载体是生物制药行业成熟的技术,与搅拌槽式生物反应器相结合,可为大规模生产贴壁细胞提供必要的环境。用于生产微载体的可生物降解材料可以解决体外疾病建模问题。

          根据最终用户,微载体市场细分为制药和生物技术公司、合同研究组织和合同制造组织以及学术和研究机构。制药和生物技术公司部门在 2022 年占据了最大的市场份额。预计同一部门在预测期内的市场复合年增长率最高,为 12.9%。制药公司在药品总产量中占有很大的份额。制药制造工艺通常基于生物技术原理,涉及使用细菌生产胰岛素、人类生长激素和其他产品。制药和生物技术行业在过去十年中经历了广泛的增长,这主要是由于研发活动的增加以及监管部门对引入新微生物产品的批准。如此大规模的创新预计将在未来几年推动生物反应器在制药和生物技术制造中的应用,最终有利于微载体市场的增长。

           

          区域分析:

          根据地理位置,全球微载体市场分为北美、欧洲、亚太、南美和中美以及中东和非洲。2022 年,北美占全球微载体市场规模的最大份额。预计亚太地区在 2022-2030 年期间的复合年增长率最高。

          北美的微载体市场分为美国、加拿大和墨西哥。该地区市场的增长归因于生物技术和生物制药公司推出的产品数量不断增加、主要市场参与者的存在以及各种学术和研究机构的广泛研发等因素。美国是北美和世界微载体市场的最大贡献者。美国市场的增长主要归因于慢性病患病率的上升。根据疾病控制和预防中心 (CDC) 的数据,每 10 个美国人中就有 6 个患有至少一种慢性疾病,例如糖尿病、心脏病和中风、癌症。这些疾病是美国死亡和残疾的主要原因,也导致医疗保健费用高昂。细胞和基因疗法 (CGT) 领域取得了广泛的临床发展,因此这些疗法的应用范围在过去 5 年中得到了扩大。随着 2016-2021 年 12 种新疗法获批和 2,900 多项临床试验的开始,CGT 创新领域已获得大量投资。基因编辑技术的进步,以及随后进行的临床试验以评估该技术的治疗效果,是使美国微载体市场受益的其他因素。Poseida Therapeutics, Inc. 获得了美国食品药品监督管理局 (FDA) 批准其 P-CD19CD20-ALLO1 的新药临床试验 (IND) 申请,这是该公司首个针对 CD19 和 CD20 抗原的同种异体双 CAR-T 细胞候选产品,用于治疗复发或难治性 B 细胞恶性肿瘤,正在与罗氏合作开发。2023 年 4 月,新型同种异体 CAR T 细胞疗法在转移性透明细胞肾细胞癌患者中取得了成果。

          增加临床试验的参与度和投资可以加速新疗法的采用和可用性。德克萨斯大学 MD 安德森癌症中心的研究人员领导了 I 期试验,并在 2023 年美国癌症研究协会 (AACR) 年会上发表了演讲,代表研究人员不断努力推进临床研究并扩大已获批准药物的可能建议,以开发更有效的治疗平台并改善患者预后。2023 年 8 月,安斯泰来制药公司和 Poseida Therapeutics, Inc. 宣布了一项战略投资,以支持 Poseida 致力于重新定义癌细胞疗法的进展。安斯泰来投资 5000 万美元,授权 Poseida 的一项临床阶段项目 P-MUC1C-ALLO1,这是一种用于多种实体瘤适应症的同种异体 CAR T 细胞疗法。因此,随着慢性病病例的增加以及不同细胞和基因疗法的批准,美国对微载体的需求正在上升。

           

          微载体市场报告范围

          报告属性细节
          2022 年市场规模16.3亿美元
          2030 年的市场规模41.8亿美元
          全球复合年增长率(2022 - 2030 年)12.5%
          历史数据2020-2021
          预测期2023-2030
          涵盖的领域按产品
          • 培养基和试剂
          • 微载体珠
          按设备
          • 生物反应器
          • 培养容器
          • 其他的
          按应用
          • 生物制药生产
          • 细胞和基因治疗
          • 组织工程与再生医学
          • 其他的
          按最终用户
          • 制药和生物技术公司
          • 合同研究组织和合同制造组织
          • 学术及研究机构
          覆盖地区和国家北美
          • 我们
          • 加拿大
          • 墨西哥
          欧洲
          • 英国
          • 德国
          • 法国
          • 俄罗斯
          • 意大利
          • 欧洲其他地区
          亚太
          • 中国
          • 印度
          • 日本
          • 澳大利亚
          • 亚太其他地区
          南美洲和中美洲
          • 巴西
          • 阿根廷
          • 南美洲和中美洲其他地区
          中东和非洲
          • 南非
          • 沙特阿拉伯
          • 阿联酋
          • 中东和非洲其他地区
          市场领导者和主要公司简介
          •  
          • 帝人株式会社
          • Bio-Rad 实验室公司
          • denovoMATRIX有限公司
          • 赛多利斯公司
          • 丹纳赫公司
          • 康宁公司
          • 艾本德
          • Percell Biolytica 公司
          • 旭化成公司
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

           

          行业发展和未来机遇:

          以下列出了微载体市场主要参与者采取的各种举措:

          1. 2023 年 6 月,帝人株式会社推出了用于快速发展的大规模细胞培养的新型无纺布微载体。这种支架物质可促进三维粘附,促进多种细胞类型的生长。
          2. 2022 年 5 月,圣戈班生命科学公司发布了用于间充质基质细胞 (MSC) 的 beadMATRIX。beadMATRIX 是即用型预涂层微载体,不含动物成分,可用于体外培养优质 MSC。摇床袋、搅拌罐、垂直轮生物反应器和摇床烧瓶是 beadMATRIX 的理想环境。
          3. 2023 年 6 月,圣戈班生命科学的投资部门 NOVA 宣布对 denovoMATRIX 进行投资。作为专注于干细胞治疗市场相关产品的主服务协议的延伸,双方旨在巩固双方关系,从而利用圣戈班生命科学的全球影响力和 denovoMATRIX 团队的创新产品线。

           

          竞争格局和重点公司:

          帝人株式会社、Bio-Rad Laboratories Inc、denovoMATRIX GmbH、Sartorius AG、丹纳赫公司、康宁公司、Eppendorf SE、Percell Biolytica AB、旭化成公司和 Polysciences Inc 是微载体市场的主要公司。这些公司专注于新技术、现有产品的升级和地域扩张,以满足全球日益增长的消费者需求。

          Microcarriers Market Report Scope

          Report Attribute Details
          Market size in US$ 1.63 Billion
          Market Size by US$ 4.18 Billion
          Global CAGR 12.5%
          Historical Data 2020-2021
          Forecast period 2023-2030
          Segments Covered By 产品(培养基、试剂、微载体珠)
          By 设备(生物反应器、培养容器等)
          By 应用(生物制药生产、细胞和基因治疗、组织工程和再生医学等)
          By 最终用户(制药和生物技术公司、合同研究组织和合同制造组织以及学术和研究机构)
          Regions and Countries Covered 北美(美国、加拿大、墨西哥)
          • 北美(美国、加拿大、墨西哥)
          欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          Market leaders and key company profiles
        • Teijin Ltd
        • Bio Rad Laboratories Inc
        • denovoMATRIX GmbH
        • Sartorius AG
        • Danaher Corp
        • Corning Inc
        • Eppendorf SE
        • Percell Biolytica AB
        • Asahi Kasei Corp
        • Report Coverage
          Report Coverage

          Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

          Segment Covered
          Segment Covered

          This text is related
          to segments covered.

          Regional Scope
          Regional Scope

          North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

          Country Scope
          Country Scope

          This text is related
          to country scope.

          Frequently Asked Questions


          Who are the major players in the Microcarriers Market?

          The Microcarriers Market majorly consists of the players such as Teijin Ltd, Bio-Rad Laboratories Inc, denovoMATRIX GmbH, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Percell Biolytica AB, Asahi Kasei Corp, Polysciences Inc.

          What is Microcarriers Market?

          Microcarriers provide an efficient way to analyze biological data collected from different cell types. This data can be used to discover new drugs and therapies. The rising demand for automated and miniaturized products is anticipated to drive the growth of the microcarriers market. Additionally, the increasing demand for specialized products and services is also expected to contribute to the growth of the microcarrier industry.

          What are the driving factors for the Microcarriers Market?

          The growth of the market is attributed to the need for cell therapies with rising incidence of cancer and infectious diseases, and increasing popularity of outsourcing cell and gene therapy manufacturing boost the market growth. However, the high cost of biologics and cell-based therapies hampers the market growth.

          Which segment is dominating the Microcarriers Market?

          The Microcarriers Market is analyzed on product, equipment, application, and end users. Based on product, the market is segmented into microcarrier beads and media & reagents. Based on equipment, the market is segmented into bioreactors, culture vessels, and others. Based on application, the market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and others. The biopharmaceutical production segment is subsegmented into therapeutic protein and vaccine production. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations and contract manufacturing organizations, and academic and research institutes.

          The List of Companies - Microcarriers Market

          1. Teijin Ltd
          2. Bio-Rad Laboratories Inc
          3. denovoMATRIX GmbH
          4. Sartorius AG
          5. Danaher Corp
          6. Corning Inc
          7. Eppendorf SE
          8. Percell Biolytica AB
          9. Asahi Kasei Corp
          10. Polysciences Inc

          The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

          1. Data Collection and Secondary Research:

          As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

          Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

          1. Primary Research:

          The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

          For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

          A typical research interview fulfils the following functions:

          • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
          • Validates and strengthens in-house secondary research findings
          • Develops the analysis team’s expertise and market understanding

          Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

          • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
          • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

          Below is the breakup of our primary respondents by company, designation, and region:

          Research Methodology

          Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

          1. Data Analysis:

          Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

          • Macro-Economic Factor Analysis:

          We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

          • Country Level Data:

          Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

          • Company Profile:

          The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

          • Developing Base Number:

          Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

          1. Data Triangulation and Final Review:

          The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

          We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

          We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

          Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

          Trends and growth analysis reports related to Biotechnology : READ MORE..